Ivermectin Remdesivir Leronlimab

Latest updates about the Ivermectin, Remdesivir, and Leronlimab

Donate to support this work:
https://paypal.me/mobeensyed?locale.x=en_US

Ivermectin’s in vitro viral inhibition study
https://www.sciencedirect.com/science/article/pii/S0166354220302011

A preprint (yet to be peer reviewed) study
https://www.medrxiv.org/content/10.1101/2020.06.06.20124461v2


A private health group in Dominican Republic finds good results from Ivermectin
https://www.trialsitenews.com/president-of-dominican-republics-largest-private-health-group-discusses-the-success-of-ivermectin-as-a-treatment-for-early-stage-covid-19/


Remdesivir
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

Gilead’s press release for Remdesivir SIMPLE trial
https://www.gilead.com/news-and-press/press-room/press-releases/2020/6/gilead-announces-results-from-phase-3-trial-of-remdesivir-in-patients-with-moderate-covid-19

Remdesivir May 22nd study (I believe this study allowed WHO to approve their emergency use authorization.)
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home

Remdesivir pricing
https://www.npr.org/sections/health-shots/2020/06/29/884648842/remdesivir-priced-at-more-than-3-100-for-a-course-of-treatment

Leronlimab
https://www.targetedonc.com/view/cemiplimab-upholds-efficacy-in-3-year-follow-up-for-advanced-cutaneous-squamous-cell-carcinoma
https://www.cytodyn.com/pipeline/covid-19

Phase III trial in Mexico
https://markets.businessinsider.com/news/stocks/cytodyn-and-nih-of-mexico-complete-memorandum-of-understanding-to-conduct-small-covid-19-phase-3-trial-for-severe-and-critically-ill-patients-1029349155#